Valuation: SMS Pharmaceuticals Limited

Market Cap 4.67TCr 50Cr 45Cr 41Cr 37Cr 70Cr 72Cr 490.74Cr 195.68Cr 2.49TCr 186.43Cr 182.44Cr 7.86TCr P/E 2025
27.3x
P/E 2026 33.6x
Enterprise Value 4.99TCr 53Cr 48Cr 43Cr 40Cr 75Cr 77Cr 524.28Cr 209.05Cr 2.66TCr 199.17Cr 194.9Cr 8.4TCr EV / Sales 2025
2.75x
EV / Sales 2026 4.31x
Free-Float
24.01%
Yield 2025
0.19%
Yield 2026 0.11%
1 day-3.51%
1 week+2.62%
Current month-2.50%
1 month+4.33%
3 months+36.76%
6 months+23.77%
Current year+60.62%
1 week 471.25
Extreme 471.25
535
1 month 405
Extreme 405
535
Current year 293.15
Extreme 293.15
535
1 year 270.1
Extreme 270.1
535
3 years 113.3
Extreme 113.3
535
5 years 54.55
Extreme 54.55
535
10 years 24
Extreme 24
535
Manager TitleAgeSince
Chief Executive Officer 66 30/08/1990
Director of Finance/CFO - 13/09/2017
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 66 30/08/1990
Director/Board Member 38 05/06/2020
Director/Board Member 48 29/05/2018
Change 5-day change 1-year change 3-year change Capi.($)
-3.51%+2.62%+77.51%+316.50% 51Cr
-0.79%-4.48%+44.44%+127.49% 1,21600Cr
+1.43%+1.11%+47.73%+82.08% 66TCr
+1.07%-1.21%+32.99%+106.31% 51TCr
-0.36%-2.84%+47.23%+64.51% 38TCr
-0.14%-1.87%+71.05%+40.63% 36TCr
-0.78%+0.59%+31.01%+59.68% 31TCr
-0.80%+6.73%+11.89%+35.64% 29TCr
+0.03%-1.20%+45.89%+68.76% 25TCr
-0.41%-2.22%+35.24%+105.68% 21TCr
Average -0.63%+1.18%+44.50%+100.73% 41.88TCr
Weighted average by Cap. -0.31%+0.04%+42.48%+88.51%

Financials

2025 2026
Net sales 782.75Cr 8.33Cr 7.47Cr 6.83Cr 6.23Cr 12Cr 12Cr 82Cr 33Cr 417.66Cr 31Cr 31Cr 1.32TCr 888.64Cr 9.45Cr 8.48Cr 7.75Cr 7.07Cr 13Cr 14Cr 93Cr 37Cr 474.16Cr 35Cr 35Cr 1.5TCr
Net income 69Cr 73.55L 65.96L 60.29L 55.03L 1.04Cr 1.07Cr 7.27Cr 2.9Cr 37Cr 2.76Cr 2.7Cr 116.46Cr 101.99Cr 1.08Cr 97.31L 88.93L 81.18L 1.53Cr 1.58Cr 11Cr 4.27Cr 54Cr 4.07Cr 3.99Cr 171.8Cr
Net Debt 269.27Cr 2.86Cr 2.57Cr 2.35Cr 2.14Cr 4.04Cr 4.17Cr 28Cr 11Cr 143.67Cr 11Cr 11Cr 453.57Cr 319.08Cr 3.39Cr 3.04Cr 2.78Cr 2.54Cr 4.79Cr 4.94Cr 34Cr 13Cr 170.25Cr 13Cr 12Cr 537.47Cr
Projected Income Statement - Annual - SMS Pharmaceuticals Limited
Logo SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in the business of manufacturing active pharma ingredients and their intermediates. Its product categories include anti-ulcer, anti-inflammatory, anti-migraine, ant-diabetic, anti-coagulant, anti-viral, anti-retroviral, anti-psychotic, and others. The Company products include ranitidine, famotidine, pantoprazole sodium, itraconazole, lanoconazole, luliconazole, ibuprofen, Dex ibuprofen, fenoprofen calcium, sumatriptan, almotriptan, zolmitriptan, rizatriptan, Ele triptan, vildagliptin, sitagliptin, rosiglitazone, empagliflozin, dapagliflozin, tenofovir, dolutegravir, raltegravir, lamivudine, efavirenz, apixaban, rivaroxaban, levetiracetam, perampanel, lamotrigine, penciclovir, valaciclovir, and others. The Company has manufacturing facilities at Bachupally, Hyderabad, Telangana and also at Kandivalasa Village, Poosapatirega Mandal, Vijayanagaram District, Andhra Pradesh.
Employees
1,617
Date Price Change Volume
06/26/06 ₹498.55 -3.51% 3,95,857
05/26/05 ₹516.70 -1.67% 7,70,206
04/26/04 ₹525.50 +2.21% 20,00,587
03/26/03 ₹514.15 +1.98% 6,68,734
02/26/02 ₹504.15 -1.41% 8,24,268

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - SMS Pharmaceuticals Limited
  1. Stock Market
  2. Stocks
  3. SMSPHARMA Stock